Mimetis

At first, Mimetis Biomaterials was a biomedical company that started as a spin-off. Originally, it derived from the Biomaterials, Biomechanics and Tissue Engineering (BBT) group of the Polytechnic University of Catalonia (UPC). 

First, the problem particularly was that then available bone graft substitutes were so far outdated. In addition, they could not adapt to cover the increasing need for bone regeneration at that time. Unquestionably, the challenge was the absence of biomimetic product that allows:

Above all, the formation of new bone that is by all means highly vascularized. Accordingly, it results in high interaction with soft tissue. Also, it minimizes inflammation. Furthermore, an important option was the possibility to customize it, occasionally, where patient-specific customization is crucial and mandatory.  

Consequently, Key Opinion Leaders in the dental and orthopaedic sectors then designed MimetikOss. They then validated the bone graft substitute, along with researchers in Tissue Engineering. Eventually, everybody who participated in this process, became shortly after, either partner or investor.

Therefore, Mimetis undoubtedly answers all those features a surgeon especially needs in a bone graft substitute. Today, it offers MimetikOss, a biomimetic synthetic bone graft substitute that mimics the mineral part of the bone, contributing to the formation of a highly vascularized bone, and patient-specific when necessary. Also,  the adjustments of the impression allow to obtain an open and interconnected porosity that favors the vascularization and the colonization of the tissues. In conclusion, MimetikOss is versatile and covers bone regeneration needs up to the most challenging cases. Don’t forget to inquire about our patient-specific solution!